Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4 (2-nitrophenyl) -3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552)
Kazda, S.; Garthoff, B.; Meyer, H.; Schlossmann, K.; Stoepel, K.; Towart, R.; Vater, W.; Wehinger, E.
Arzneimittel-Forschung 30(12): 2144-2162
1980
ISSN/ISBN: 0004-4172 PMID: 7194077 Document Number: 168439
Document emailed within 1 workday
Related Documents
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Safak, C.; Simsek, R.; Altas, Y.; Boydag, S.; Erol, K. 1997: 2-methyl-3-acetyl-4-aryl-5-oxo-1,4-dihydro-5H indeno(1,2-b) pyridine derivatives studies and their calcium antagonistic activities Bollettino Chimico Farmaceutico 136(11): 665-669
Tomczyk, H.; Rogaczewska, T. 1979: Gas-chromatographic determination of methyl-isobutyl ketone, methyl-isobutyl carbinol, acetone, toluene and o-xylene vapors in the air Medycyna Pracy 30(6): 417-423
Kirchner, K.; Berge, H. 1975: Determination of methyl parathion (0.0-dimethyl-(p-nitrophenyl)-thiophosphoric acid ester) and metabolites in animal material and in feed Archiv für Experimentelle Veterinarmedizin 29(5): 643-647
Krivonkin, K.I.; Belousov, I.B. 1991: Clinical pharmacology of nisoldipine, a new calcium antagonist Kardiologiia 31(9): 100-105
Engelhardt, G. 1975: On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist Arzneimittel-Forschung 25(11): 1723-1737
Kano, T.; Nakamura, S.; Nishi, K. 1988: Effects of a newly synthetized calcium antagonist, cyclopropylmethyl 4-(3-nitrophenyl) 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate (MPC-2101), on action potentials of rabbit's myocardial tissues in vitro Archives Internationales de Pharmacodynamie et de Therapie 296: 101-117
Asami, Y.; Otsuka, M.; Hirohashi, T.; Inaba, S.; Yamamoto, H. 1974: The synthesis and pharmacology of a novel benzodiazepine derivative, 1-methyl-5-(o-fluorophenyl)-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one(ID-540) Arzneimittel-Forschung 24(10): 1563-1568
Zarghi, A.; Faizi, M.; Abdolahnejad, R.; Fassihi, A. 2003: Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates Bollettino Chimico Farmaceutico 142(4): 175-179
Takenaka, T.; Usuda, S.; Nomura, T.; Maeno, H.; Sado, T. 1976: Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93) Arzneimittel-Forschung 26(12): 2172-2178
Moron, J.; Rautureau, M.; Huel, C.; Pierré, A.; Berthier, L.K.; Atassi, G.; Bisagni, E. 1993: Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives Anti-Cancer Drug Design 8(6): 399-416
Tauscher, M.; Eckhardt, G.; Geisel, B.; Schroeder, G. 1977: Isolation and structure determination of the metabolites of 2-(1,3-dimethyl-xanthinyl-(7)-methyl)-4-methyl-morpholine--a xantinol derivative--from rat urine Arzneimittel-Forschung 27(12): 2344-2347
Lin, J.K.; Sung, S.S. 1975: Comparative studies on the carcinogenecities of N, N-dimethyl-4-aminoazobenzene and N'-acetyl-N'-methyl-4'-amino-N, N-dimethyl-4-aminoazobenzene in a normal diet Journal of the Formosan Medical Association 74(8): 534-540
Eigenmann, R.; Blaber, L.; Nakamura, K.; Thorens, S.; Haeusler, G. 1981: Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies Arzneimittel-Forschung 31(9): 1393-1401
Matsui, K. 2001: Synthesis of quinoxaline-3,4-dihydro-6,7-dimethyl-3-keto-4-D-ribityl-2-carboxamide Osaka City Medical Journal 47(1): 1-9
Alaoui, M.A.; Gayral, P.; Kirkiacharian, S. 1993: Research of antiparasitic agents: 1(nitrophenyl)-3-(methyl-3-indolyl)-prop-2-ene-1-ones (Nitroindolylchalcones) Annales Pharmaceutiques Francaises 51(5): 260-265
Tarpley, W.G.; Miller, J.A.; Miller, E.C. 1980: Adducts from the reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with deoxyguanosine or DNA in vitro and from hepatic DNA of mice treated with N-methyl- or N,N-dimethyl-4-aminoazobenzene Cancer Research 40(7): 2493-2499
Kirkiacharian, S.; Alaoui, M.A.; Ouidren, M.; Gayral, P. 1996: Synthesis and antiparasitic activity of new N-alkyl derivatives of 1-(nitrophenyl)-3-(methyl-3-indolyl)-prop-2-ene-1-ones (nitroindolylchalcones) Annales Pharmaceutiques Francaises 54(6): 272-275